Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

KNDS Learns Tanks Can’t Outrun the Market

2 weeks ago 9

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

KNDS Learns Tanks Can't Outrun the Market

KNDS Learns Tanks Can't Outrun the Market - Moby

THE GIST

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

KNDS has postponed its planned stock market listing, proving that even a tank maker can hit a roadblock. The Franco-German defense group had hoped to float about 20% of its shares in Paris and Frankfurt, but weak sentiment across European defense stocks made the timing too risky. Europe still wants more weapons. Investors just want proof that government promises will turn into earnings before they pay top-of-the-cycle valuations.

WHAT HAPPENED

KNDS said it will delay its planned IPO because of market volatility in the European defense sector.

The company, which makes Leopard 2 tanks, Leclerc tanks, Caesar howitzers and other land defense systems, had recently confirmed plans to list shares in Paris and Frankfurt. The offering was expected to be one of Europe's biggest defense IPOs in years.

The plan was to float about 20% of the company to institutional investors, with France and Germany each keeping 40% stakes. KNDS was formed in 2015 through the merger of Germany's Krauss-Maffei Wegmann and France's Nexter, making it a central player in Europe's land warfare industry.

The delay follows reports that KNDS was struggling to win support for a valuation above €12 billion. Earlier estimates had floated numbers as high as €25 billion, but expectations have fallen as defense stocks have retreated.

KNDS said it has completed the required preparation work for the listing and held extensive talks with potential investors. The company said those discussions confirmed support for its strategy and market position, but shareholders decided to wait for better market conditions.

The fundamentals still look strong. KNDS generated €4.4 billion in revenue in 2025, with EBIT of €661 million and an order backlog of €33.1 billion. The company expects revenue to rise close to 30% this year and has medium-term ambitions to reach annual sales of €11 billion to €12 billion.

WHY IT MATTERS

This is a reality check for Europe's rearmament trade.

The simple story was powerful. Russia invaded Ukraine. Europe realized it had underinvested in defense. Governments pledged hundreds of billions of euros in military spending. Defense companies suddenly looked like rare European growth stocks with political tailwinds, full order books and very serious hardware.

Then investors remembered that governments are not Amazon Prime.

Defense spending takes time. Budgets need approval. Contracts get delayed. Programs get redesigned. Coalitions argue. Ministries change their minds. A press conference does not become revenue just because someone says "strategic autonomy" three times.

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway